Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times (Q6642070)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times |
scientific article; zbMATH DE number 7947990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times |
scientific article; zbMATH DE number 7947990 |
Statements
Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times (English)
0 references
21 November 2024
0 references
cellular therapy
0 references
dose finding
0 references
natural killer cells
0 references
phase I--II clinical trial
0 references
precision medicine
0 references
